Richard Ferrari



Mr. Ferrari is a Co-Founder of De Novo Ventures which has $650 million under management and which is one of the premier firms dedicated to medical devices and biotechnology. Mr Ferrari has extensive experience in the medical devices sector, including being CEO of Cardiovascular Imaging Systems (the first and leading developer of ultrasound imaging catheters acquired by Boston Scientific) and CardioThoracic Systems (the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery acquired by Guidant). Mr Ferrari also co-founded the Medical Technology Group which spun-out Integrated Vascular Systems, acquired by Abbott Vascular and Ensure, acquired by J&J.